Biotech Competitive Due Diligence 
Alpha Sense BI
AUGUST 30, 2023
As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Now integrated into nearly every industry, genAI is fast becoming a must-have for any firm that aims to get the competitive edge.
Alpha Sense BI
MAY 28, 2024
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alpha Sense BI
APRIL 29, 2024
Traditional due diligence for start-up investors has historically been riddled with inefficiencies—tying up resources to sort through countless documents and copious amounts of data, and manually crafting market comparisons and performance. There is no doubt that generative AI has emerged as a powerful tool in the investment space.
Alpha Sense BI
APRIL 19, 2024
2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. trillion market evaluation by 2032 due to the ever-increasing number of companies integrating this technology. OpenAI’s ChatGPT ). Start your free trial today.
Alpha Sense BI
APRIL 12, 2024
Generally, expert calls provide investment researchers with the operator’s perspective, which is critical to understanding competitive moats and enhancing data-driven research with soft data. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’ It’s one of those things.
Alpha Sense BI
MAY 5, 2023
2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.
Engage3
MAY 19, 2022
He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. Adi received his B.S. in Applied Mathematics and B.A. Helena Cisneros Sr. He holds B.A. He is also an entrepreneur.
Expert insights. Personalized for you.
98 
Let's personalize your content